Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Orion Oyj - SIC # 7352 - MEDICAL EQUIPMENT RENTAL AND LEASING
Ticker
Exchange
SIC #
Website
Latest Ticker
ORINY
Over the counter
7352
www.orion.fi
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Orion Oyj
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
- Feb 12th, 2025 7:00 pm
Save the Date: Orion’s Capital Markets Day on 22 May 2025
- Feb 10th, 2025 12:00 pm
3 Reliable Dividend Stocks Offering Yields Up To 4.5%
- Jan 31st, 2025 6:04 pm
Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics
- Jan 30th, 2025 2:00 pm
Orion publishes Financial Statement Release for 2024 and holds a webcast on 25 February 2025
- Jan 28th, 2025 7:00 am
Inside information: Orion upgrades full-year outlook for 2024 and provides preliminary information on financial performance for 2024
- Jan 15th, 2025 4:25 pm
Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2025 Annual General Meeting
- Jan 15th, 2025 8:45 am
79,345 Orion Corporation A shares converted into B shares
- Jan 13th, 2025 7:50 am
Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide
- Jan 7th, 2025 7:00 am
3 Leading Dividend Stocks Yielding Up To 8.5%
- Jan 2nd, 2025 9:03 pm
Orion and Marinus terminate agreement for ganaxolone in Europe
- Dec 30th, 2024 12:00 pm
CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel
- Dec 19th, 2024 8:45 pm
Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel
- Dec 19th, 2024 5:00 pm
Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
- Dec 18th, 2024 3:00 pm
Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction
- Dec 12th, 2024 6:30 pm
142,701 Orion Corporation A shares converted into B shares
- Nov 27th, 2024 7:00 am
3 Prominent Dividend Stocks For November 2024
- Nov 26th, 2024 2:08 am
Orion Research Foundation grants EUR 1,109,000 for research in 2025
- Nov 22nd, 2024 7:00 am
Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
- Nov 19th, 2024 4:30 pm
Orion Corporation: Managers’ transactions – Henrik Stenqvist
- Nov 1st, 2024 7:45 am
Scroll